Personalized precision medicine powered by AI for cancer therapy
Stage
Not given
Not given
Founded
Not given
Not given
Based in
AU
US
Pricing model
Not given
Contact for pricing
Pricing
Free app with optional paid devices: I'M SAFE Tag Classic, I'M SAFE Tag Pro (rechargeable, IP67 water-resistant), I'M SAFE Alarm Classic (135 dB), and I'M SAFE Alarm Metal physical devices available for purchase.
Not given
Key features
Private Bubble groups for choosing who to share with
Journey feature to follow trip progress until ended
Zones with arrival and departure notifications at saved places
SOS alerts to selected Bubble contacts with live location
Live location links shareable for 1, 3 or 7 hours
Private Vault with AES-256-GCM encryption for notes, photos and files
Chat within Bubbles
Optional Bluetooth SOS Tags with physical button
Standalone Personal Alarms with 135 dB siren without phone required
Community in select cities with moderated guides and conversations
Analyzes digital pathology with no additional tissue staining required
Rapid results within 1-2 days after specimen receipt
Validated across diverse populations including African American and non-African American men
FDA De Novo authorization for prostate cancer risk stratification
Insurance coverage for Medicare and many commercial plans
Provides 5 and 10-year distant metastasis risk for breast cancer
Identifies breast cancer patients who benefit from chemotherapy
Included in NCCN Clinical Practice Guidelines for Prostate Cancer
What makes it different
Works as free app alone with no device purchase required
User controls all sharing: invite-only Bubbles with individual on/off for each group
Does not contact emergency services; focuses on connection to chosen trusted people
Emphasis on relationship support and preparation rather than surveillance
Optional devices available: rechargeable water-resistant Tags or standalone alarms
No additional tissue preparation needed, uses existing H&E slides
Validated across multiple large randomized phase III clinical trials
FDA De Novo clearance as Software as a Medical Device
Financial assistance program to make tests affordable regardless of income